AngioDynamics (ANGO)
(Delayed Data from NSDQ)
$7.42 USD
-0.13 (-1.72%)
Updated Aug 27, 2024 03:59 PM ET
After-Market: $7.40 -0.02 (-0.27%) 7:58 PM ET
1-Strong Buy of 5 1
B Value B Growth F Momentum B VGM
Industry / Sector Report
Industry : Medical - Instruments
Zacks Industry Rank
Top 29% (72 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.70 | 9.99 |
Current Quarter Estimate | -0.15 | 4.85 | 61.00 |
Year Ago Quarter Estimate | -0.12 | 3.57 | 54.84 |
Next Quarter Estimate | -0.10 | 5.64 | 63.00 |
Next Year Estimate | -0.25 | 24.53 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -7.89 | 12.50 | 15.67 |
Next Year | 39.02 | 22.60 | 11.34 |
Last 5 Years | -192.60 | 10.20 | 8.10 |
Next 5 Years | NA | 13.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 8.00 |
Price/Book (MRQ) | 1.47 | 2.48 |
Price/Cash Flow (MRFY) | 1.76 | 17.57 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -61.55% | -28.06% |
Return on Equity (TTM) | -4.91% | -24.58% |
Debt to Equity (MRQ) | 0.00 | 10.64 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.